TickerFactsScreenerDevelopers

PharmaCyte Biotech, Inc. (PMCB) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$1.95M2013: -$1.68M2014: -$18.98M2015: -$13.26M2016: -$6.07M2017: -$4.44M2018: -$6.98M2019: -$4.10M2020: -$3.83M2021: -$3.62M2022: -$4.39M2023: -$6.46M2024: -$8.52M2025: -$4.38M-$4.38M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$4.38M+48.6%
2024-$8.52M-32.0%
2023-$6.46M-47.0%
2022-$4.39M-21.2%
2021-$3.62M+5.3%
2020-$3.83M+6.7%
2019-$4.10M+41.3%
2018-$6.98M-57.2%
2017-$4.44M+26.9%
2016-$6.07M+54.2%
2015-$13.26M+30.1%
2014-$18.98M-1026.8%
2013-$1.68M+13.6%
2012-$1.95M—